Cathepsin S inhibitors: WO2010070615

Bibliography

• Lecaille F, Kaleta J, Bromme D. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 2002;102:4459-88
   PubMed Web of Science ®Google Scholar
• Vasiljeva O, Reinheckel T, Peters C, Emerging roles of cysteine cathepsins in diseases and their potential as drug targets. Curr Pharm Des 2007;13:387-403
   PubMed Web of Science ®Google Scholar
• Reiser J, Adair B, Reinheckel T. Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 2010;120:3421-31
   PubMed Web of Science ®Google Scholar
• Honey K, Rudensky AY. Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 2003;3:472-82
   PubMed Web of Science ®Google Scholar
• Beers C, Burich A, Kleijmeer MJ, Cathepsin S controls MHC class II-mediated antigen presentation of epithelial cells in vivo. J Immunol 2005;175:1205-12
   Google Scholar
• Saeguas K, Ishimura N, Yanagi K, Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest 2002;110:361-9
   PubMed Web of Science ®Google Scholar
• Yang H, Kala M, Scott BG, Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis. J Immunol 2005;174:1729-37
   PubMed Web of Science ®Google Scholar
• Gupta S, Singh RK, Dastidar S, Ray A. Cysteine cathepsin S as an immunomodulatory target: present and future trends. Expert Opin Ther Targets 2008;12:291-9
   PubMed Web of Science ®Google Scholar
• Zavasnik-Bergant T, Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 2006;67:349-55
   PubMed Web of Science ®Google Scholar
• Semple JE, Owens TD, Nguyen K, Levy OE. New synthetic technology for efficient construction of alpha-hydroxy-beta-amino amides via the passerini reaction. Org Lett 2000;2:2769-72
   PubMed Web of Science ®Google Scholar
• Catalano JG, Deaton DN, Long ST, Design of small molecule ketoamide-based inhibitors of cathepsin K. Bioorg Med Chem Lett 2004;14:719-22
   PubMed Web of Science ®Google Scholar
• Link JO, Zipfel S. Advances in cathepsin S inhibitor design. Curr Opin Drug Discov Dev 2006;9:471-82
   PubMed Web of Science ®Google Scholar
• Wiener JJM, Sun S, Thurmond RL. Recent advances in the design of cathepsin S inhibitors. Curr Top Med Chem 2010;10:717-32
   PubMed Web of Science ®Google Scholar
• McGrath ME, Palmer JT, Bromme D, Somoza JR. Crystal structure of human cathepsin S. Protein Sci 1998;7:1294-302
   PubMed Web of Science ®Google Scholar
• Ayesa S, Lindquist C, Agback T, Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity. Bioorg Med Chem 2010;17:1307-24
   Web of Science ®Google Scholar
• Fissolo N, Kraus M, Reich M, Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur J Immunol 2009;38:2401-11
   Web of Science ®Google Scholar
• Clark AK, Yip PK, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci 2009;29:6945-54
   PubMed Web of Science ®Google Scholar
• Gao Y-J, Ji R-R. Chemokines, neuronal–glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010;126:56-68
   PubMed Web of Science ®Google Scholar
• Reddy VB, Shimada SGS, Sikand P, Cathepsin S elicits itch and signals via protease-activated receptors. J Invest Dermatol 2010;130:1468-70
   PubMed Web of Science ®Google Scholar
• Soh UJK, Dores MR, Chen BX, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol 2010;160:191-203
   PubMed Web of Science ®Google Scholar
• Asokananthan N, Graham PT, Stewart DJ, House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002;169:4572-8
   PubMed Web of Science ®Google Scholar
• Deschamps K, Cromlish W, Weicker S, Genetic and pharmacological evaluation of cathepsin S in a mouse model of asthma. Am J Respir Cell Mol Biol 2011; In press
   Google Scholar
• Asfaha S, Cenac N, Houle S, Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 2007;150:176-85
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Bunnett NW, Sharkey KA, Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001;7:821-6
   PubMed Web of Science ®Google Scholar
• Angelastro MR, Mehdi S, Burkhart JP, alpha-Diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. J Med Chem 1990;33:11-13
   PubMed Web of Science ®Google Scholar
• Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-50
   PubMed Web of Science ®Google Scholar
• Driessen C, Bryant RAR, Lennon-Dumenil A-M, Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritc cells. J Cell Biol 1999;147:775-90
   PubMed Web of Science ®Google Scholar